Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Sorry about the malfunction . THEN WHO

very true. but i think pohl deserves some credit. the S&L situation has been a part of PTSC since day 1. the market has valued ptsc at $7 (grant it a lot less shares outstanding) in the past and most recently $2.25. This is naturally only my opinion... i think the market wants to see this mean and lean little company actually execute. to date, they have not. TPL has. Read the bios on the BOD and see if this looks like a savy group of high techies. Dutton stated we are a company of 5 employees....sounds like a small lean company...except the employees are BOD members and live in different parts of the country. I wonder how many of them have actually visited the office space. I just think a new BOD would give the market reason to evaluate PTSC with a different perspective and possibly award the company with a PE that implies at least a some future growth.

best of luck, t'moto

Share
New Message
Please login to post a reply